News
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
21hon MSN
Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.
Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...
Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...
4h
WPBF Channel 25 on MSNHow Google's new AI technology is being used this hurricane seasonNOAA will be collaborating with Google's DeepMind and will evaluate the new models and provide feedback to Google's AI ...
Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...
Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...
18h
GlobalData on MSNIsomorphic Labs prepares to launch trials for AI-designed drugsAlphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...
Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...
A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...
For a company long defined by proprietary development, this move is a symbol of a broader technological undercurrent sweeping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results